74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Elevance Health Inc
Closed
SectorHealthcare
429.03 0.33
Overview
Share price change
24h
Min
418.08
Max
429.1
Income | -603M 413M |
|---|---|
Sales | 742M 45B |
P/E Sector Avg | 15.849 57.333 |
EPS | 3.84 |
Dividend yield | 1.68 |
Profit margin | 0.909 |
Employees | 104,200 |
EBITDA | 1.3B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +15.87% upside |
Dividend yield Sector Avg | 1.68% 2.63% |
|---|---|
Next Earnings | 16 Jul 2025 |
Next Dividend date | 25 Jun 2025 |
Next Ex Dividend date | 10 Jun 2025 |
Market Cap | 4.3B 96B |
|---|---|
Previous open | 428.7 |
Previous close | 429.03 |
Elevance Health Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Elevance Health Inc Forecast
Price Target
By TipRanks
15.87% upside
12 Months Forecast
Average 494.6 USD 15.87%
High 585 USD
Low 428 USD
Based on 16 Wall Street analysts offering 12 month price targets forElevance Health Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
